Cargando…
Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
Recurrent squamous cell carcinoma of the skin is a rare but difficult to treat condition. Frequently, the disease presents itself in elderly patients with poor performance status and bearing many comorbidities, thus the decision to administer systemic chemotherapy becomes difficult to make. In addit...
Autores principales: | Seber, Selcuk, Gonultas, Aylin, Ozturk, Ozlem, Yetisyigit, Tarkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772919/ https://www.ncbi.nlm.nih.gov/pubmed/26955287 http://dx.doi.org/10.2147/OTT.S96227 |
Ejemplares similares
-
Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting
por: Seber, Selcuk, et al.
Publicado: (2016) -
Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
por: Falivene, Sara, et al.
Publicado: (2014) -
Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018) -
Complete response of recurrent oral squamous cell carcinoma treated with cetuximab in combination with radiotherapy: A case series
por: Naruse, Tomofumi, et al.
Publicado: (2022) -
Dramatic response of refractory metastatic squamous cell carcinoma of the
skin with cetuximab/pembrolizumab
por: Hober, Candice, et al.
Publicado: (2021)